(Q44511397)

English

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

Angela Dispenzieri

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

12

object named as

Tefferi A

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

13

object named as

Litzow MR

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

8

object named as

Gertz MA

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

11

object named as

Lacy MQ

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Howe R

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Micallef IN

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Inwards DJ

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ansell SM

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Dewald GW

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gastineau DA

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Geyer SM

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Hanson CA

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

317-324

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704124

0 references

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

21 January 2018

Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplasia and acute leukemia after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal myelodysplastic cells present in apheresis product before transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704124

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704124

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44511397&oldid=2025996491"